Our finding that mutations in murine Arhgef12 and Prkci modulate Crb1rd8 retinal phenotypes to differing extents and with different lesion characteristics further supports the hypothesis that modifier gene variants contribute to clinical variability in CRB1-associated retinal dystrophy. The gene discussed is ARHGEF12; the disease is Retinal dystrophy.